Pharmaceuticals Stocks

Actavis plc Annual Valuation – 2015 $ACT

Actavis-logoBenjamin Graham taught that Intelligent Investors must do a thorough fundamental analysis of investment opportunities to determine their intrinsic value and inherent risk.  This is best done by utilizing a systematic approach to analysis that will provide investors with a sense of how a specific company compares to another company or by reviewing the 5 Most Undervalued Companies for the Defensive Investor – March 2015.  By using the ModernGraham method one can review a company’s historical accomplishments and determine an intrinsic value that can be compared across industries.  What follows is a specific look at how Actavis plc (ACT) fares in the ModernGraham valuation model.

Defensive Investor – must pass at least 6 of the following 7 tests: Score = 1/7

  1. Adequate Size of Enterprise – market capitalization of at least $2 billion - PASS
  2. Sufficiently Strong Financial Condition – current ratio greater than 2 - FAIL
  3. Earnings Stability – positive earnings per share for at least 10 straight years - FAIL
  4. Dividend Record – has paid a dividend for at least 10 straight years - FAIL
  5. Earnings Growth – earnings per share has increased by at least 1/3 over the last 10 years using 3 year averages at beginning and end of period – FAIL
  6. Moderate PEmg ratio – PEmg is less than 20 - FAIL
  7. Moderate Price to Assets – PB ratio is less than 2.5 or PB x PEmg is less than 50 - FAIL

Enterprising Investor – must pass at least 4 of the following 5 tests or be suitable for a defensive investor: Score = 0/5

  1. Sufficiently Strong Financial Condition, Part 1 – current ratio greater than 1.5 - FAIL
  2. Sufficiently Strong Financial Condition, Part 2 – Debt to Net Current Assets ratio less than 1.1 - FAIL
  3. Earnings Stability – positive earnings per share for at least 5 years - FAIL
  4. Dividend Record – currently pays a dividend - FAIL
  5. Earnings growth – EPSmg greater than 5 years ago - FAIL

Valuation Summary

Key Data:

Balance Sheet – December 2014

Current Assets $6,882,000,000
Current Liabilities $5,019,000,000
Total Debt $14,846,000,000
Total Assets $52,529,000,000
Intangible Assets $43,710,000,000
Total Liabilities $24,198,000,000
Outstanding Shares 265,600,000

Earnings Per Share

2014 -$7.42
2013 -$5.27
2012 $0.76
2011 $2.06
2010 $1.48
2009 $1.96
2008 $2.09
2007 $1.27
2006 -$4.37
2005 $1.21
2004 $1.21

Earnings Per Share – ModernGraham

2014 -$3.35
2013 -$0.81
2012 $1.50
2011 $1.84
2010 $1.31
2009 $0.96

Dividend History
Actavis does not pay a dividend.


Actavis is not suitable for the Enterprising Investor or for the Defensive Investor.  In fact, the company only passes the Defensive Investor’s requirement regarding size, a result which is extremely rare and would seem to indicate a very poor financial position.  As a result, value investors following the ModernGraham approach based on Benjamin Graham’s methods should explore other opportunities at this time.  From a valuation side of things, the company appears to be overvalued after seeing its EPSmg (normalized earnings) drop from $1.31 in 2010 to a loss of $3.35 for 2014.  This significant lack of demonstrated growth does not support a positive valuation, leading the ModernGraham valuation model, based on Benjamin Graham’s formula, to return an estimate of intrinsic value below the price.

The next part of the analysis is up to individual investors, and requires discussion of the company’s prospects.  What do you think?  What value would you put on Actavis (ACT)?  Where do you see the company going in the future?  Is there a company you like better?  Leave a comment on our Facebook page or mention @ModernGraham on Twitter to discuss.

Disclaimer:  The author did not hold a position in Actavis (ACT) or in any other company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  Logo taken from Wikipedia for the sole purpose of identifying the company; this article is not affiliated with the company in any manner.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back To Top